Shattuck Labs (STTK) Total Current Liabilities (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Total Current Liabilities of $4.2 million for Q1 2026, down 41.91% year-over-year from $7.3 million in Q1 2025, and down 39.75% quarter-over-quarter from $7.1 million in Q4 2025.
Shattuck Labs (STTK) Total Current Liabilities (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Total Current Liabilities for 8 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 41.91% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 41.91% YoY), while the FY2025 annual figure was $7.1 million, down 20.92% from the prior year.
- Total Current Liabilities fell to $4.2 million in Q1 2026 per STTK's latest filing, from $7.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $25.0 million in Q4 2022 and bottomed at $4.2 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $12.9 million across 5 years, with a median of $13.0 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 60.45% — and 2025, when it slumped 64.49%.
- Shattuck Labs' Total Current Liabilities stood at $25.0 million in 2022, then sank by 54.12% to $11.5 million in 2023, then declined by 22.14% to $8.9 million in 2024, then fell by 20.92% to $7.1 million in 2025, then sank by 39.75% to $4.2 million in 2026.
- Business Quant data shows STTK's Total Current Liabilities at $4.2 million in Q1 2026, $7.1 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.73 Mn |
| Mar 31, 2026 | 4.25 Mn |
| Dec 31, 2025 | 7.05 Mn |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Mar 31, 2025 | 7.32 Mn |
| Dec 31, 2024 | 8.92 Mn |
| Sep 30, 2024 | 12.40 Mn |
| Jun 30, 2024 | 15.03 Mn |
| Mar 31, 2024 | 14.33 Mn |
| Dec 31, 2023 | 11.45 Mn |
| Sep 30, 2023 | 14.06 Mn |
| Jun 30, 2023 | 12.99 Mn |
| Mar 31, 2023 | 16.01 Mn |
| Dec 31, 2022 | 24.97 Mn |
| Sep 30, 2022 | 19.14 Mn |
| Jun 30, 2022 | 24.25 Mn |
| Mar 31, 2022 | 16.81 Mn |
| Dec 31, 2021 | 24.59 Mn |
| Sep 30, 2021 | 19.84 Mn |